76
Participants
Start Date
September 30, 2004
Primary Completion Date
July 31, 2011
cetuximab
cisplatin
University of Mississippi Cancer Clinic, Jackson
MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland
Cleveland Clinic Taussig Cancer Center, Cleveland
Ochsner Cancer Institute at Ochsner Clinic Foundation, New Orleans
Christus Schumpert Cancer Treatment Center, Shreveport
Oklahoma University Cancer Institute, Oklahoma City
Cancer Care Associates - Midtown Tulsa, Tulsa
Providence Saint Joseph Medical Center - Burbank, Burbank
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City
Fox Chase Virtua Health Cancer Program at Virtua West Jersey, Voorhees Township
Wake Forest University Comprehensive Cancer Center, Winston-Salem
Fox Chase Cancer Center - Philadelphia, Philadelphia
McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center, Reading
University of Texas Medical Branch, Galveston
M. D. Anderson Cancer Center at University of Texas, Houston
Collaborators (1)
National Cancer Institute (NCI)
NIH
Bristol-Myers Squibb
INDUSTRY
Gynecologic Oncology Group
NETWORK